InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,738.17
(
-0.13%
)
US TECH 100
19,436.00
(
-0.73%
)
Dow Jones
42,313.00
(
0.33%
)
Brent Oil
71.98
(
0.38%
)
Bitcoin
64,431.58
(
-1.82%
)
Post# of 253252
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120509
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ciotera post# 104057

Monday, 09/13/2010 2:11:22 PM

Monday, September 13, 2010 2:11:22 PM

Post# of 253252
Re: Size of HCV bolus

Don't know where you are getting your estimates of "roughly half" from, but I won't argue them because I don't have anything better.

They are from the market research done by VRTX, which was discussed on the webcast last week. VRTX estimates that the US market has 300-350K diagnosed patients who have never been treated and 270-300K patients who failed at least one course of therapy.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up